Dartmouth researchers have discovered that immune cells called macrophages play opposing roles in cancer, with some fighting tumors, while others help them grow. A study published in Nature Immunology points to a more precise approach to cancer treatment by selectively blocking the cells that suppress the body’s natural defenses, using a drug already approved by the FDA.